Choice - Best Stock Broker in India
  • About
  • App
  • Services
    Services
  • Research
  • Partners
  • Contact
  • Log In
  • Open Demat Account
  • Home
  • Blog
  • ...
  • Aarti Industries And UPL Form Partnership to Increase Specialty Chemical Production
  • ...
    Aarti Industries And UPL Form Partnership to Increase Specialty Chemical Production

Aarti Industries And UPL Form Partnership to Increase Specialty Chemical Production

Aarti Industries And UPL Form Partnership to Increase Specialty Chemical Production
  • Published Date: May 24, 2024
  • Updated Date: May 24, 2024
  • By Team Choice
Following the announcement of a 50/50 joint venture for specialty chemicals, the share prices of UPL and Aarti Industries soar.

Early trading saw a jump in the shares of UPL and Aarti Industries in response to the news of a joint venture agreement aimed at producing specialized chemicals. On May 24, shares of UPL were trading at ₹518.65, up 1.52% on the NSE, and shares of Aarti Industries were trading at ₹646.65, up 3.03%.

A press release from UPL on May 23rd states that the joint venture will function as a 50-50 partnership, with an emphasis on producing and distributing specialized chemicals that are essential to a range of downstream sectors.

The supply of downstream amine derivatives, which are utilized in paints and fertilizers for agriculture, will be the main emphasis of the JV. The joint venture, which seeks to address the need for high-value chemical solutions worldwide, will leverage the complementary strengths of Aarti Industries and UPL in order to take advantage of synergies in raw material supply and production knowledge.

The joint venture, called Augene Chemical Private Limited (ACPL), is anticipated to start making money in Q1FY27 and reach a maximum yearly income of ₹400–500 crore in the next two to three years. The two corporations will contribute ₹12.50 crore each in equity shares of ACPL as their initial investment. Over the course of about 24 months, the two partners will invest a total of ₹137.50 crore, which will include debt financing and cash investments.

Raj Tiwari, CEO of UPL's Specialty Chemical Business, expressed optimism on the partnership as a landmark deal between two Indian chemical industry leaders committed to delivering innovative speciality chemicals globally. He added “This collaboration is in line with our broader strategy of expanding into downstream derivatives of newer chemistries to spearhead the growth of specialty chemicals platform. This arrangement will leverage on long-standing relationship between UPL and AIL and the manufacturing capabilities of the two Companies.”

Recommended for you

loading

FII DII Data - Live Data

loading

Indian Stock Market Prediction For Next Week

loading

10 Best SIP Plans For ₹1000 Per Month in 2025

loading

Pharma Mutual Funds – Best Option to Invest in 2025?

Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.

Choice Financial Services
  • Services

  • Stocks
  • Mutual Funds
  • Wealth Planning
  • Insurance
  • Loans
  • Capital Advisory
  • Management Consultancy
  • Government Advisory
  • Institution
  • Company

  • Our Team
  • Investors
  • Calculator
  • Careers
  • Contact Us
  • Refer & Earn
  • FAQ’s
  • Resources

  • Fundamental
  • Technical
  • Blog
  • Pricing
  • Downloads
  • News & Media
  • Offer Document
  • Track Record
  • Investor Charter
  • Investor Grievances
  • Online KYC Updation
  • Quick Links

  • Open Demat Account
  • Corporate Demat Account
  • NRI Demat Account
  • Minor Demat Account
  • Market Prediction
  • Lowest Brokerage
  • Investor Charter
  • Investor Awareness
  • Watchout Investors
  • Investor's Advisory
  • Disclaimer
  • CEBPL Policies & Disclosures
  • CFPL Policies & Disclosures
  • Sachet Portal
  • Direct Pay-in

Choice International Limited , Sunil Patodia Tower,
J B Nagar, Andheri(East),
Mumbai 400099.

Monday - Friday : 08:30 am - 7:00 pm
Saturday : 10:00 am - 4:00 pm

+91-88-2424-2424

care@choiceindia.com

Google Play
App StoreApp Store
  • Made with in India
  • Privacy Policy
  • Terms & Conditions

Choiceinternational. CIN - L67190MH1993PLC071117
Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ).
Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015 , DP ID CDSL - 12066900 , NSDL ID - IN301895. Research Analyst - INH000000222
Choice Wealth Private Limited: AMFI - Registered Mutual Fund Distributor. Association of Mutual Funds in India Registration Number - ARN - 78908.
Initial Registration: 15th March 2010 Valid Till: 14th March 2027.
Pension Fund Regulatory and Development Authority (PFRDA) - POPSE52022022 | Affiliated with POP HDFC Pension Management Company.
Choice Finserv Private Limited: NBFC Registration Number : N - 13.02216

Choice Insurance Broking Private Limited: IRDAI License No: 167, License Valid Till: 29-05-2025 | Category : Direct ( Life & General )
Registered Office: Choice International Limited, Sunil Patodia Tower, J B Nagar, Andheri East, Mumbai, Maharashtra 400099.
For any Grievances / Queries email at ig@choiceindia.com & care@choiceindia.com | Online Dispute Resolution Link: https://smartodr.in/login

Cautionary Message :

  1. Sharing of trading credentials – login id & passwords including OTP’s:- Keep Your Password/Pin and OTP’s private & confidential to avoid any misuse or unauthorised trades. Please ensure that you do not share it with any one.
  2. Trading in leveraged products like options without proper understanding, which could lead to losses
  3. Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
  4. Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  5. Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers

Disclaimer:
1. *Investments in securities market are subject to market risks, read all the related documents carefully before investing.
2. In addition to client based business, we are also doing proprietary trading.
3. Brokerage will not exceed the SEBI prescribed limit.

Research Disclaimer and Disclosure inter-alia as required under Securities and Exchange Board of India (Research Analysts) Regulations, 2014

Choice Equity Broking Private Limited (“CEBPL”) is a registered Research Analyst Entity (Reg. No. INH000000222 ) (hereinafter be referred as “CEBPL”). (CIN. NO.: U65999MH2010PTC198714).

Reg. Address: Sunil Patodia Tower, J B Nagar, Andheri(East), Mumbai 400099. Tel. No. 022-6707 9999 .

Compliance Officer: Mr.Prashant Salian. Tel. 022-67079999 - Ext-2310
Email- Prashant.salian@choiceindia.com

Grievance officer: Deepika Singhvi Tel.022-67079999- Ext-834.
Email- ig@choiceindia.com

Research Disclaimer: Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© Choice International Limited. All Rights Reserved.